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INTRODUCTION
With the revolutionary developments in sequencing technolo-
gies,1 molecular testing is now widely used to support clinical 
diagnosis and to identify unknown causes of genetic disor-
ders.1–3 There are several approaches to evaluating the effect of 
a variant: (i) evidence-based, (ii) frequency-based, (iii) func-
tional (variants with obviously drastic consequences such as 
nonsense and frameshift mutations), and (iv) predictive.4 The 
first three approaches are successful in determining the effects 
of variants but are limited when it comes to the variants of 
unknown significance.1 For novel variants, which comprise the 
majority of coding variation,5 in silico prediction is a quick way 
is to estimate potential consequences. Computational tools, 
such as PolyPhen6 and SIFT,7 are frequently used to evalu-
ate genetic variations; however, they are not yet at the level 
of desired performance in terms of sensitivity and specificity, 
even for  well-studied monogenic Mendelian diseases.4,8,9 These 
tools take into account the following key parameters: sequence 
conservation, structural constraints, and physiochemical prop-
erties of amino acids and known annotations, such as func-
tionally important sites. Risk estimation is largely dependent 
on the molecular conservation, which is inferred from com-
parative sequence analysis,10 and is based on the fact that most 
 disease-causing mutations cause a reduction of evolutionary 
fitness; therefore, they are not selected for and are not observed 
in homologs in other organisms.9 To identify homologous 
sequences in other organisms, current tools use automated 
sequence similarity searches followed by multiple sequence 
alignment (MSA) and clustering. Consequently, sets of simi-
lar sequences that are used in the downstream analysis usually 
include both orthologs and paralogs.6 This approach is based on 
the argument that disease-causing substitutions far more often 
affect protein structure than function,11 and although paralo-
gous proteins may have a slightly different function, their struc-
ture is fully conserved.
However, the roles of paralogous genes in disease and health 
are different. In most cases of Mendelian diseases, only one of 
the paralogous genes is associated with the disease.12 In 87% of 
the gene pairs, only one pair is associated with disease, and this 
trend is observed in gene families with more than two mem-
bers. Once a gene is duplicated, purifying selection pressure 
on one or both of the copies is relaxed and they become more 
prone to accumulating mutations. This divergence can lead to 
sub-functionalization or neofunctionalization,13 often resulting 
in different roles of paralogs in disease.
This pattern is observed in Niemann-Pick disease type C 
(NP-C), which is a neurovisceral lysosomal lipid storage dis-
ease.14–16 NP-C is inherited in an autosomal recessive pattern and 
is caused by mutations in either NPC1 or NPC2 genes.17 NPC1 
and NPC2 proteins work in concert to transport cholesterol from 
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Purpose: Predicting the phenotypic effects of mutations has become 
an important application in clinical genetic diagnostics. Computa-
tional tools evaluate the behavior of the variant over evolutionary 
time and assume that variations seen during the course of evolution 
are probably benign in humans. However, current tools do not take 
into account orthologous/paralogous relationships. Paralogs have 
dramatically different roles in Mendelian diseases. For example, 
whereas inactivating mutations in the NPC1 gene cause the neuro-
degenerative disorder Niemann-Pick C, inactivating mutations in its 
paralog NPC1L1 are not disease-causing and, moreover, are impli-
cated in protection from coronary heart disease.
Methods: We identified major events in NPC1 evolution and revealed 
and compared orthologs and paralogs of the human NPC1 gene 
through phylogenetic and protein sequence analyses. We predicted 
whether an amino acid substitution affects protein function by reduc-
ing the organism’s fitness.
Results: Removing the paralogs and distant homologs improved 
the overall performance of categorizing disease-causing and benign 
amino acid substitutions.
Conclusion: The results show that a thorough evolutionary analysis 
followed by identification of orthologs improves the accuracy in pre-
dicting disease-causing missense mutations. We anticipate that this 
approach will be used as a reference in the interpretation of variants 
in other genetic diseases as well.
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the endosomal/lysosomal compartment.16,18 Homozygous loss 
of function in either protein perturbs lipid homeostasis, which 
results in pathogenicity. Ninety-five percent of affected indi-
viduals carry pathogenic mutations in the NPC1 gene,15 which 
recently attracted attention because of its role in the entry of the 
Ebola virus.19 By contrast, the NPC1 paralog, NPC1L1, is not 
associated with the disease. On the contrary, inactivating muta-
tions in NPC1L1 reduce the risk of coronary heart disease.20 
NPC1 deletion in mice causes hearing loss,21 defects in retina,22 
and deficiency in cerebellum development,23 whereas NPC1L1 
deficiency protects ApoE-/- mice against atherosclerosis.24
Diagnosis of NP-C is challenging because of the heterogene-
ity in symptoms and clinical presentation.16 Until recently, the 
diagnostic standard was filipin staining of unesterified choles-
terol in fibroblasts obtained by skin biopsy.25,26 This test, how-
ever, is definitive in only approximately two-thirds of cases. 
NP-C diagnostics has been significantly improved through 
the discovery of cholesterol oxidation products (“oxysterols”) 
that are elevated in the plasma of NP-C subjects.27 The plasma 
oxysterol assay detects >97% of cases with 100% sensitivity.28 
DNA sequencing offers another tool for NP-C diagnostics, but 
in practice detects only ~85% of NP-C cases due to the large 
number of private and noncoding sequence mutations.29 For 
novel missense mutations, in silico tools are indispensable for 
predicting potential NP-C. However, these tools use different 
algorithms and data sets to build MSAs to assess the variant 
effect, resulting in substantial inconsistencies.30 Researchers 
usually rely on agreement between several tools, which has the 
effect of increasing specificity while decreasing the sensitivity.31 
Moreover, the tools that use conservation information do not 
discriminate between orthologous and paralogous proteins6 
and thus include NPC1 paralogs, such as NPC1L1, in their 
analysis. Although including paralogs in risk-estimating data 
sets is convenient (this eliminates computationally demanding 
and often nontrivial steps to separate orthologs and paralogs), 
such simplification confounds the function-specific signal.
NP-C disease caused by NPC1 mutations is an ideal case 
study to understand the effects of paralogs in predicting 
 disease-causing mutations because of a dramatic consequence 
of the duplication event that yielded NPC1L1. Moreover, many 
experimentally validated disease-causing mutations as well as 
alleles with high frequencies that are likely to be benign are 
known for this gene (Supplementary Table S1 online).
In this study, we established the precise evolutionary history of 
the NPC1 gene and identified evolutionary events that most likely 
affected its function. We used this information to build a compu-
tational approach that showed improved accuracy in categorizing 
damaging and benign single amino acid substitutions in NPC1.
MATERIALs AND METHODs
Databases, multiple sequence alignments, and 
phylogenetic trees
Human NPC1 protein (NM_000271.4) was queried through 
BLASTP32 against the human genome to reveal the related 
sequences. Each hit was blasted individually against the RefSeq 
database. For each job, the full sequences were compiled and 
aligned using MAFFT default algorithm.33 Neighbor joining 
tree was built with the phylip package.34 From the tree, the 
NPC1 homologs clade was isolated. With the retrieved homo-
logs, MAFFT version v7.154b E-INS-i algorithm was used to 
realign the full-length sequences. The phylogenetic trees were 
built using the maximum likelihood approach with PHYML 
software version 2014092935 and applying the JTT substitution 
model and the remaining parameters as default. The outgroups 
that were not considered to be NPC1 homologs based on 
RefSeq annotations and domain architectures were discarded 
from the MSA, NPC1 homologs were realigned, and the final 
phylogenetic tree was built.
Orthology assignment
Orthologs and paralogs were distinguished using the maxi-
mum likelihood phylogenetic tree. In case of major duplica-
tion events, a consistently more divergent duplicated clade was 
categorized as paralogs that are less likely to retain the original 
NPC1 function. The reference point for evolutionary distance 
was determined as the full-length NPC1 node. In the cases in 
which no divergence consistency between clades was observed 
(e.g., not all species in clade A were more diverged than those 
in clade B, or incomplete species set in both clades), the orthol-
ogy assignment was deemed inconclusive. For the species-level 
duplications, the sequence, which was significantly diverged 
from the closest node of NPC1 orthologs, was categorized as 
paralogous.
scoring the effect of single amino acid variants
PubMed 1997–2014 database was searched to identify relevant 
studies and case series. The initial search resulted in 312 arti-
cles. General review articles on NP-C disease, articles lacking 
genetic testing, and experimental findings not connected with 
clinical data were excluded. As a result, we identified 56 articles 
referencing a total of 572 mutations in the NPC1 gene. After 
excluding repetitive reports, insertion/deletion, frameshift and 
nonsense mutations, and benign SNPs, the final list of the most 
likely pathogenic nsSNVs comprised 166 variants that were 
referred to as “damaging” variants in this study. To retrieve the 
set of “benign” mutations, we used frequencies in human popu-
lations reported by Wassif et al.31 The variants found in humans 
with higher frequency than the most common deleterious vari-
ant, I1063T, were categorized as benign. However, we removed 
N222S, N961S, S1200G, and A521S from this list due to the 
reports suggesting that they might be damaging.
In MSA, misaligned amino acids are masked based on the 
queried position. First, residues adjacent to ambiguous amino 
acids (represented by X) are masked. Second, if a sequence 
has insertion or deletion in close proximity to the position of 
interest, then that residue is masked. Selection of the represen-
tative isoform also depends on the queried position. Because 
of the variations in splice sites, a single representative isoform 
may not align well with the rest of the proteins for each posi-
tion. Therefore, selection of the representative isoform based 
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on the queried position yields better alignment quality. In the 
algorithm, the “moderately variable” category was defined as 
a position having more than five different substitutions in a 
given set. Position was categorized as “hypervariable” if there 
were more than nine different substitutions (see the source 
code and related input files such as MSA and phylogenetic tree 
at http://genomics.utk.edu/saver/source.rar).
statistical analyses
The performance of the algorithm is described by the following 
parameters: sensitivity; specificity; false discovery rate; accuracy; 
F1 score; and Matthews correlation coefficient. In the equations 
given here, TP, TN, FP, and FN refer to the number of true posi-





Accuracy = TP + TN
TP + TN + FP + FN
FDR = 1  TP
TP + FP




 + FP + FN
MCC = TP TN  FP FN
(TP + FP)(TP + FN)(TN + F
× − × 
N)(TN + FP)
Domain architecture prediction and risk map generation
To build domain architectures, we used the CDvist Web server 
with HMMER3 against Pfam 27.0 and HHsearch against 
 Protein Data Bank options.36,37 Protein Data Bank HHsearch 
probability cutoff was adjusted to 98%.
We implemented the SAVER algorithm in a PYTHON3 script 
and ran it on all theoretical human NPC1 amino acid variants. 
For each position, we counted the allowed (benign) amino 
acids. The range was between 0 (no substitution allowed) and 
19 (any substitution allowed). For secondary structure infor-
mation, X-ray crystal structure (protein data bank ID: 3GKH) 
was used for N-terminal domain and Psipred prediction was 
used for the rest. The Protter Web application was used to gen-
erate the NPC1 membrane topology figure.38
REsULTs
Distinct clusters of NPC1 homologs suggest different 
functions
NPC1 protein has 13 transmembrane (TM) regions with three 
luminal domains. The crystal structure of the N-terminal 
domain has been solved with bound cholesterol, indicating its 
role in cholesterol binding and transport.39 The pentahelical 
sterol-sensing domain, which resides between TM3 and TM8, 
is required for cholesterol egress from the lysosome. There are 
nine human genes that share similarity through their sterol-
sensing domains and are identifiable by BLASTP initiated with 
NPC1: NPC1, NPC1-L1, PTCH1, PTCH2, PTCHD2, PTCHD3, 
PTCHD4, SCAB SREBF, and DISP. These related proteins also 
share the “Patched” domain, which has a role in cholesterol-
dependent processes. Domain architectures of these proteins 
show significant differences, with only NPC1 and NPC1-L1 con-
taining the N-terminal cholesterol-binding domain (Figure 1a). 
A phylogenetic tree constructed from the MSA of all Patched 
domain proteins shows distinct clades, where the NPC1-
NPC1L1 clade is clearly separated from the rest (Figure  1b). 
These findings strongly suggest that other Patched-containing 
sequences should not be taken into account when examining 
function-specific characteristics of NPC1. In contrast, auto-
mated tools often include such functionally unrelated sequences 
in their data sets (Supplementary Figure S1 online).
Major events in NPC1 evolution
NPC1 is found in four of the five eukaryotic supergroups—
unikonta, plants, chromalveolata, and excavates—and is miss-
ing from rhizaria. Phylogenetic analysis of NPC1 protein shows 
that the NPC1 gene followed vertical evolution. Thus, it is likely 
that NPC1 was present in the last eukaryotic common ances-
tor. Multiple gene duplication events are observed in taxonomic 
ranks from superorder to species level; among 397 species with 
NPC1, 195 (49%) have more than one copy (Supplementary 
Figure S2 online).
In the common ancestor of gnathostomata (jawed ver-
tebrates), the NPC1 gene was duplicated, giving rise to the 
“NPC1-like” protein, which is present in most jawed verte-
brates including humans (named NPC1L1). The NPC1L1 clade 
is greatly diverged from the root when compared to the gna-
thostomatan NPC1 clade (Figure 2). NPC1 is present in each 
organism that has NPC1-L1; however, the opposite is not true. 
Moreover, the NPC1L1 clade has a longer average branch length 
from its root, indicating a greater divergence (Supplementary 
Figure S3 online). The NPC1L1 divergence and dispensabil-
ity strongly suggest that its function is different from that of 
NPC1, which is consistent with the observation that muta-
tions in NPC1-L1 do not cause the disease. We observed a very 
similar pattern of NPC1 duplication in neoptera (Figure 2 and 
Supplementary Figure S3 online).
In fungi and amoebozoa, several duplications occurred, but 
only at the species and genus level, suggesting there was no 
major duplication event in these kingdoms.
In plants, there was NPC1 duplication in the common ances-
tor of flowering plants. More than one paralog is observed in 
Pentapetalae. However, the distances of two clades from the 
root are comparable (Figure  2). Furthermore, some organ-
isms have only one version of the gene from either clade, 
which suggests that one paralog is sufficient and neither copy is 
indispensable. Internal diversity was comparable in two clades 
GENETICs in MEDICINE  |  Volume 18  |  Number 10  |  October 2016
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(Supplementary Figure S3 online). Therefore, the paralogs 
may not have gained significantly different functions. Thus, the 
Homo sapiens NPC1 (HsNPC1) orthology assignment cannot 
be precisely performed in plants.
Unikonts (metazoa, fungi, and amoebozoa) and plants have 
the full-length NPC1 protein with 13 TM regions, except for 
Dictyostelium (Supplementary Figure S4 online). They all 
accommodate a lumenal N-terminal domain that binds to 
cholesterol. However, in Naegleria gruberi (excavate) and 
in most chromalveolates, this domain is missing, resulting 
in a shorter protein with 12 TM regions (Supplementary 
Figure S4 online). We found that all organisms that lack the 
NPC1 N-terminal domain have a separate protein (~300 amino 
acids) encoded in their genomes, which is homologous (~30% 
identity, ~50% similarity) to the N-terminal domain of the 
full-length HsNPC1. Oomycetes have both “full” and “short” 
versions of NPC1. In the phylogenetic tree, these two versions 
are distinctly separated. Except for Nannochloropsis gaditana 
(which has an atypical NPC1 with no sterol-sensing domain), 
all organisms with the short version of the NPC1 protein 
also have the separate cholesterol-binding protein. Moreover, 
the separate  cholesterol-binding protein is found exclusively 
in the organisms that have the short NPC1. The separate 
 cholesterol-binding protein is predicted to have a signal peptide 
at the N-terminus and a TM region at the C-terminus. Thus, 
concatenation of the separate cholesterol-binding protein and 
the short version of NPC1 substantially resembles HsNPC1. 
Exclusive coexistence of these two proteins suggests that they 
interact and function similarly to the full version of NPC1. The 
existence of both “full” and “short” versions in oomycetes and 
the vertical evolutionary patterns suggest that both versions 
could have been present in the last eukaryotic common ances-
tor, where either fusion or dissociation could have occurred; 
then, only one version was kept in all organisms, except for 
oomycetes, in which both were kept.
In addition to major duplication events, in each kingdom 
there were also species and/or genus level duplications. In such 
cases, one copy evolves slowly to keep the original function 
and the extra copies, which are not prone to the same levels 
of purifying selective pressure, diverge faster. We used the dis-
tance measurements from the common ancestor node in the 
phylogenetic tree to determine the slowest evolving gene (the 
clade with a shorter branch distance to the common ances-
tor), which in turn enabled us to find the functional orthologs. 
Figure 1 Relationships between Patched domain–containing proteins. (a) The domain architectures of human Patched domain–containing proteins were 
retrieved using the CDvist Web server. Boxes with a white background represent PFAM domains. Cholesterol-binding domains (in blue) were retrieved using a 
PDB database profile. The cholesterol-binding domain was found exclusively in NPC1 and NPC1L1. (b) Some pairs such as PTCH1-PTCH2, NPC1-NPC1L1, and 
PTCHD3-PTCHD4 have a relatively recent common ancestor, whereas the other proteins are related to each other more distantly, as they are represented as 
single clades on the phylogenetic tree. According to the phylogenetic tree, the NPC1-NPC1L1 clade is clearly separated from other Patched domain–containing 
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Notably, NPC1 was lost in many parasites including whole 
clades, such as microsporidia (fungi) and apicomplexa (chro-
malveolata). Except for N. gruberi, all species sequenced in the 
Excavata supergroup are parasitic (Trypanosomatidae family, 
Trichomonas vaginalis, and Giardia intestinalis) and contain no 
NPC1 in their genomes.
Defining HsNPC1 functional orthologs
Products of orthologous genes are very likely to perform the 
same function. Therefore, distinguishing HsNPC1 ortho-
logs from other homologous proteins is critical for identi-
fying potentially pathogenic variants specifically affecting 
HsNPC1 function. Detailed analysis of the phylogenetic tree 
of all NPC1 homologs guided HsNPC1 orthology assign-
ment. The clades retaining the original NPC1 function were 
determined based on the agreement of three lines of evi-
dence. First, we compared the distances of duplicated clades 
to the full-length NPC1 root (Figure  2) to identify which 
one is less diverged. Second, we compared the organism con-
tent of the clades. If a clade is a subset of another, then the 
superset clade was considered the “original” one representing 
HsNPC1 orthologs. Finally, diversity within the clades was 
assessed; the less diverged clade is more likely to be ancestral 
(Supplementary Figure S3 online). When all three criteria 
agree, HsNPC1 orthologs can be identified with confidence. 
However, in some cases, the sequence divergence informa-
tion was inconclusive. In those cases, none of the clades was 
a subset of another. Moreover, the diversity within the clades 
was comparable. Consequently, these sequences were not 
included in the set of HsNPC1 orthologs.
Evaluating missense mutations in HsNPC1: the scoring 
algorithm
Our master MSA included all homologs. We divided the mas-
ter MSA into three sets grouped by the orthology relationships 
(see Figure  2 for details). The phylogenetic clade containing 
HsNPC1 after the most recent major evolutionary event, which 
is the birth of NPC1L1 in gnathostomata, was considered the 
core alignment. This alignment, referred to as “Set 1,” was 
given the highest importance in the evaluation algorithm. Set 2 
includes Set 1 and also other unambiguous HsNPC1 orthologs. 
Finally, Set 3 contained all other HsNPC1 homologs, including 
paralogs, except for the short versions of NPC1.
To predict the effect of missense mutations on HsNPC1 func-
tion, we propose an algorithm (SAVER: Single Amino Acid 
Variant Evaluator) that provides binary output from the MSA 
analysis of Sets 1 and 2 (Figure 3). In the scoring part, Set 1 is 
given the highest weight because it contains HsNPC1 and its 
orthologs that evolved after the most recent duplication and the 
birth of many Mendelian diseases correlates with the time of 
most recent duplications.12 However, using only Set 1, which is 
limited in our case to bilaterian genomes, would not be sufficient 
for collecting the entire ancestral information. For this reason, 
Set 2 was used to compensate for the lack of evolutionary depth 
in Set 1. Because Set 2 was carefully constructed from sequences 
that are likely to conserve the ancestral function of NPC1, the 
amount of false signal it introduces is limited. Furthermore, the 
possibility of false signals in Set 2 was addressed by lowering 
its priority. Because sufficient evolutionary depth was reached 
Figure 2 Maximum likelihood phylogenetic tree of NPC1 proteins 
and described sets. The star is placed at the root of full-length NPC1. On 
the left side, the black markers represent the closest NPC1 to the root for 
each organism. Green markers (Sets 1 and 2) show the orthologs, whereas 
red markers point to paralogs. Blue markers represent sequences that are 
ambiguous in terms of orthology. The gray-shaded clade contains a short 
version of NPC1. Set 1, which contains the HsNPC1 orthologs after the most 
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with Set 2, specificity was not affected drastically by excluding 
sequences only in Set 3.
Sequencing and aligning errors are key factors causing mis-
interpretation. Thus, working with the cleanest possible data 
set, a nearly perfect alignment and well-constructed phylo-
genetic trees is critical for assessing the mutations. Ab initio 
elimination of sequences that have misaligned regions is not an 
optimum solution; therefore, we apply positional masking of 
misaligned regions so that only well-aligned positions are taken 
into account. Another challenge in eukaryotic sequence com-
parison is dealing with isoforms that can redundantly dominate 
the signal and cause artificial conserved positions. We resolve 
this issue by choosing a representative isoform for each gene 
that depends on the queried position.
For a single amino acid substitution from AA0 to AA1, scor-
ing algorithms usually use the abundance of the AA1 in MSA. 
However, instead of counting the number of sequences with 
substitutions, we propose counting how many times a given 
replacement has occurred independently so that a single evo-
lutionary event would not be counted multiple times. Multiple 
independent substitutions occurring in different clades suggest 
that a position tolerates mutations, whereas a single substitu-
tion compensated by a suppressor mutation can be in a poten-
tially “irreplaceable” position.
Improved success in distinguishing between damaging and 
benign nssNVs
We scanned literature to retrieve known NPC1 variants. Only 
single amino acid substitutions were taken into account. Only 
biochemically validated NP-C–causing mutations were consid-
ered as “damaging” variants. Frequencies of HsNPC1 variants 
from several exome sequencing data sets31 were used to define 
the benign mutation data set. We selected the common variants 
that have never been shown as pathogenic in any study and that 
have frequency greater than 0.028%, which is the frequency of 
the most commonly reported pathogenic variant, I1061T. Our 
compiled control set contained 166 damaging and 21 benign 
nsSNVs (Supplementary Table S1 online).
We tested our approach in comparison with automated tools 
PolyPhen-2, SIFT, and PROVEAN.6,7,40 The results indicate that 
our approach outperforms other tools in terms of sensitivity 
(~10% improvement), while causing a relatively low cost in 
specificity, and (ii) in terms of the overall quality, as measured 
by the Matthews correlation coefficient (Table 1). The drastic 
improvement in sensitivity can be explained by the fact that our 
method eliminates the false evolutionary signals introduced by 
functionally diverged sequences that are included in the analy-
sis by other tools (Supplementary Table S1 online).
We also applied our method to all theoretical amino acid sub-
stitutions in NPC1; 24282 (1278 positions in NPC1 sequence 
X 19 amino acid substitutions) theoretical single amino acid 
variants were evaluated in comparison with the automated 
methods described above (Supplementary Table S1 online). 
Ultimately, our method predicts 81% of the variants as damag-
ing, whereas PolyPhen-2, PROVEAN, and SIFT predict 60, 70 
and 66% as damaging, respectively. Because we suspected that 
our approach overpredicts damaging variants, we adjusted the 
cutoffs of other tools to fix the damaging rate at 81%. After the 
adjustment, the performance of two methods (PolyPhen-2 and 
PROVEAN) was improved; however, none of them reached the 
quality of our approach, as measured by the Matthews correla-
tion coefficient value. Comparison between receiver-operating 
characteristics of the tools and our “sensitivity false-positive 
rate” datum shows a clear distinction of our result from the 
general trend of the others (Supplementary Figure S5 online).
An example of how inclusion of paralogous sequences might 
negatively affect the prediction is shown in Figure 4. Known 
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pathogenic mutations, N968S, G986S, G993A, and M995R (see 
Supplementary Table S1 online), are predicted as benign by all 
three automated tools, probably because the same substitutions 
are found in NPC1L1 paralogs that are included in their MSA 
sets (Figure 4). We generated a risk map for  NPC1-caused NP-C 
disease, where the topology of the human NPC1 is shown with 
the positions colored based on the number of allowed substitu-
tions (Supplementary Figure S6 online). This risk map pro-
vides clues about the functionally critical regions of HsNPC1 
(Supplementary Text S1 online), and the full list of potentially 
damaging and benign substitutions in this protein is provided 
as Supplementary Table S2 online. We have built a Web-based 
application for querying single amino acid variants in NPC1, 
which can serve as a reference for clinicians. It is freely available 
at http://genomics.utk.edu/saver/npc1.html.
DIsCUssION
In this work, we showed that it is possible to get closer to the 
desired level of predicting the effects of missense mutations 
by carefully analyzing the evolutionary history of a gene. 
A  clear improvement is accomplished by taking into consid-
eration only function-specific orthologous protein sequences. 
Remote homologs and paralogs that are likely to be function-
ally diverged should be removed from the analysis. In selecting 
functional counterparts, specific criteria based on a thorough 
phylogenetic analysis must be used.
The proposed approach depends greatly on manual work 
(constructing high-quality data sets, alignments, trees, and 
defining orthologs and paralogs) as well as reasoning, which 
depends on the output of a particular computational step. Thus, 
Table 1 Performance comparison of tools predicting the effect of NPC1 missense mutations
Tool
Damaging (166) Benign (21)
sensitivity specificity
False  
discovery rate Accuracy F1 MCCTP FN TN FP
SAVER 157 9 14 7 0.95 0.67 0.04 0.91 0.95 0.59
PP2 139 27 15 6 0.84 0.71 0.04 0.82 0.89 0.42
PROVEAN 141 25 15 6 0.85 0.71 0.04 0.83 0.90 0.43
SIFT 135 31 18 3 0.81 0.86 0.02 0.82 0.89 0.48
PP2adj 159 7 12 9 0.96 0.57 0.05 0.91 0.95 0.55
PROVEANadj 153 13 12 9 0.92 0.57 0.06 0.88 0.93 0.46
SIFTadj 150 16 11 10 0.90 0.52 0.06 0.86 0.92 0.38
The cutoffs distinguishing between “damaging” and “benign” variants are changed in the methods that are subscripted with the “adj” abbreviation based on the output 
of the SAVER computation. SAVER and other “adjusted” tools yield an 81% damaging rate in all theoretical amino acid substitutions on HsNPC1.
FN, false negative; FP, false positive; MCC, Matthews correlation coefficient; TN, true negative; TP, true positive.
Figure 4 An alignment window illustrating false effects of paralogs in predicting damaging mutations. Blue-shaded sequences are HsNPC1 
orthologs and the rest are paralogs. For each tool, the red marker represents “predicted as damaging” and the green marker represents “predicted as benign.” 
Residues highlighted in red are the potential causes of predicting pathogenic variants as benign.
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at this time, this approach cannot be fully automated and will not 
replace any of the available automated tools. However, revealing 
common trends and problems in identifying functional ortho-
logs and testing this approach on other well-defined monogenic 
Mendelian diseases should lead to the development of the next 
generation of predictive automated methods directly applicable 
in clinical practice.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper 
at http://www.nature.com/gim
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